 CHIVA group was 2.01 (95% CI,
1.34-3.00; P ‚¨ç .001).

Gloviczki et al 25S

Although the first two RCTs focused on a small group
of patients with varicose veins, the trial of Pares et al192
deserves credit for including the full spectrum of patients
with primary varicose veins. CHIVA is a complex